United Therapeutics Corp (NASDAQ:UTHR)
| 141.13 Data as of Jan 30 |  -1.44 / -1.01%Today’s Change | 84.63 Today|||52-Week Range 149.02 | +8.99% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Assets | Cash | 252.2M | 162.7M | 154.0M | 278.9M | |
| Short Term Investment Cash | 151.8M | -89.5M | -8.6M | 124.9M | ||
| Cash & Short Term Investments | 627.1M | 403.5M | 479.2M | 688.5M | ||
| Receivables | Receivables | 73.7M | 88.7M | 116.6M | 126.3M | |
| Inventories | Inventories | 35.5M | 46.0M | 37.3M | 47.8M | |
| Current Assets | Prepaid Expenses | 8.8M | 9.9M | 17.1M | 0.00 | |
| Other Current Assets | 19.4M | 14.4M | 18.3M | 46.4M | ||
| Current Assets | 764.5M | 562.5M | 668.5M | 909.0M | ||
| Total Assets | Property, Plant and Equipment - Gross | 344.2M | 419.3M | 531.7M | 571.2M | |
| Depreciation | -38.2M | -53.3M | -78.0M | -106.2M | ||
| Intangible Assets | 9.9M | 22.1M | 16.4M | 14.1M | ||
| Other Assets | 21.0M | 41.8M | 35.2M | 67.4M | ||
| Total Assets | 1.4B | 1.5B | 1.6B | 2.1B | ||
| Liabilities | Accounts Payable | 16.1M | 47.3M | 10.2M | 6.7M | |
| Short Term Debt | 236.0M | -- | 0.00 | 282.5M | ||
| Accrued Expenses | 39.0M | 40.3M | 47.0M | 58.6M | ||
| Other Current Liabilities | 165.3M | 148.4M | 140.5M | 371.6M | ||
| Other Liabilities | 428.7M | 212.6M | 176.8M | 687.7M | ||
| Total Liabilities | Long Term Debt | 68.9M | 265.6M | 275.0M | 37.9M | |
| Deferred Taxes | -202.1M | -190.7M | -150.1M | -192.7M | ||
| Other Liabilities | 39.3M | 80.5M | 80.0M | 91.9M | ||
| Total Liabilities | 536.9M | 558.7M | 531.7M | 817.4M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 883.9M | 948.5M | 1.1B | 1.3B | ||
| Total Shareholder Equity | 883.9M | 948.5M | 1.1B | 1.3B | ||
| Share Information | Common Shares Outstanding | 57.6M | 53.6M | 50.2M | 50.4M | |
| Addtl. Info. | No data currently available for this section. | |||||
.